Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?

BACKGROUND AND OBJECTIVES: The validated LabBM score (laboratory parameters in patients with brain metastases) represents a widely applicable survival prediction model, which incorporates 5 blood test results (serum lactate dehydrogenase (LDH), C-reactive protein (CRP), albumin, platelets and hemogl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieder, Carsten, Andratschke, Nicolaus H., Grosu, Anca L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126728/
https://www.ncbi.nlm.nih.gov/pubmed/37114122
http://dx.doi.org/10.3389/fonc.2023.1156161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126728/
https://www.ncbi.nlm.nih.gov/pubmed/37114122
http://dx.doi.org/10.3389/fonc.2023.1156161

Ejemplares similares